# ECOG-ACRIN Cancer Research Group: Not applicable (device, behavioral) study in Breast Ductal Carcinoma In Situ, Hematopoietic and Lymphatic System Neoplasm (448 participants)

**Score:** 65/100

| Field | Value |
|---|---|
| Sponsor | ECOG-ACRIN Cancer Research Group |
| Sponsor type | Research network |
| Study | Addressing Financial Hardship in AYA Cancer Survivors Through the Use of the New LIFT UP Intervention |
| NCT ID | NCT07909525 |
| Phase | Not applicable (device, behavioral) |
| Status | not yet recruiting |
| Conditions | Breast Ductal Carcinoma In Situ; Hematopoietic and Lymphatic System Neoplasm; Malignant Solid Neoplasm |
| Intervention types | other |
| Target enrollment | 448 |
| Posted | 2026-11-02 |
| Planned start | 2026-11-24 |
| Event | Newly registered study |
| Event date | 2026-11-02 |

## Why this score
- Posted in the last two weeks.
- 448 participants planned.
- Not yet recruiting: vendors still being chosen.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07909525). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.